Endothelial Lipase: Direct Evidence for a Role in HDL Metabolism

Total Page:16

File Type:pdf, Size:1020Kb

Endothelial Lipase: Direct Evidence for a Role in HDL Metabolism Endothelial lipase: direct evidence for a role in HDL metabolism Jonathan C. Cohen J Clin Invest. 2003;111(3):318-321. https://doi.org/10.1172/JCI17744. Commentary For the past three decades, epidemiologic studies have consistently demonstrated an inverse relationship between plasma HDL cholesterol (HDL-C) concentrations and coronary heart disease (CHD) (1). Population-based studies have provided compelling evidence that low HDL-C levels are a risk factor for CHD (2–4), and several clinical interventions that increased plasma levels of HDL-C were associated with a reduction in CHD risk (5, 6). These findings have stimulated extensive investigation into the determinants of plasma HDL-C levels. Turnover studies using radiolabeled apolipoprotein A-I, the major protein component of HDL, suggest that plasma HDL-C concentrations are highly correlated with the rate of clearance of apolipoprotein AI (7). However, the metabolic mechanisms by which HDL are catabolized have not been fully defined. Previous studies in humans with genetic deficiency of cholesteryl ester transfer protein (8), and in mice lacking the scavenger receptor BI (SR-BI) (9), have demonstrated that these proteins participate in the removal of cholesterol from HDL, while observations in individuals with mutations in hepatic lipase indicate that this enzyme hydrolyzes HDL triglycerides (10). In this issue of the JCI, reports from laboratories of Tom Quertermous (11) and Dan Rader (12) now indicate that endothelial lipase (LIPG), a newly identified member of the lipase family, catalyzes the hydrolysis of HDL phospholipids and facilitates the clearance of HDL from the circulation. Endothelial lipase was […] Find the latest version: https://jci.me/17744/pdf COMMENTARIES See the related articles beginning on pages 347 and 357. Endothelial lipase: direct evidence for a role tions of VLDL and LDL cholesterol by about 50 percent, whereas HDL-C in HDL metabolism decreased to almost zero in these ani- mals (14). These data suggested that Jonathan C. Cohen endothelial lipase may play a role in HDL catabolism. McDermott Center for Human Growth and Development, Center for Human Nutrition, To prove that endothelial lipase plays Department of Internal Medicine, University of Texas Southwestern Medical Center at Dallas, a physiological role in HDL metabo- Dallas, Texas, USA lism, both groups assessed the effects of J. Clin. Invest. 111:318–321 (2003). doi:10.1172/JCI200317744. diminished endothelial lipase activity in vivo. The Quertermous group used gene targeting to inactivate Lipg in mice. For the past three decades, epidemio- this issue of the JCI, reports from labo- Lipg–/– mice were viable and fertile and logic studies have consistently demon- ratories of Tom Quertermous (11) and had no obvious defects. Plasma choles- strated an inverse relationship between Dan Rader (12) now indicate that terol and phospholipid concentrations plasma HDL cholesterol (HDL-C) con- endothelial lipase (LIPG), a newly iden- were increased by 69 percent and 52 per- centrations and coronary heart disease tified member of the lipase family, cat- cent respectively in male Lipg–/– mice. (CHD) (1). Population-based studies alyzes the hydrolysis of HDL phospho- The changes in plasma cholesterol were have provided compelling evidence that lipids and facilitates the clearance of due primarily to an increase in plasma low HDL-C levels are a risk factor for HDL from the circulation. HDL. Despite comparable increases in CHD (2–4), and several clinical inter- Endothelial lipase was initially plasma phospholipid levels, the increase ventions that increased plasma levels of cloned by both of these laboratories in plasma cholesterol levels in female HDL-C were associated with a reduc- using entirely different strategies. Lipg–/– mice was far more modest than tion in CHD risk (5, 6). These findings Quertermous and his colleagues iden- that observed in male mice. To further have stimulated extensive investigation tified endothelial lipase as a transcript evaluate the effect of varying endothelial into the determinants of plasma HDL- that was upregulated in cultured lipase activity, Quertermous also gener- C levels. Turnover studies using radiola- human umbilical vein endothelial cells ated mice expressing a human LIPG beled apolipoprotein A-I, the major pro- undergoing tube formation (13), transgene. Consistent with the findings tein component of HDL, suggest that whereas the Rader group cloned in endothelial lipase knockout mice, plasma HDL-C concentrations are high- endothelial lipase as a transcript that overexpression of LIPG resulted in mod- ly correlated with the rate of clearance of was upregulated in the human est decreases in plasma phospholipid apolipoprotein AI (7). However, the macrophage-like cell line THP-1 and cholesterol concentrations. Rader metabolic mechanisms by which HDL exposed to oxidized LDL (14). Data- and colleagues inhibited endothelial are catabolized have not been fully base searches revealed that endothelial lipase in mice by administering a poly- defined. Previous studies in humans lipase shows strong sequence similari- clonal anti-murine endothelial lipase with genetic deficiency of cholesteryl ty to lipoprotein lipase (44 percent antibody, a strategy that has been used ester transfer protein (8), and in mice identity) and hepatic lipase (41 percent previously to assess the physiological lacking the scavenger receptor BI (SR- identity), two well-characterized lipas- roles of hepatic lipase and lipoprotein BI) (9), have demonstrated that these es that function at vascular endothelial lipase. In wild-type mice, plasma choles- proteins participate in the removal of surfaces. Critical motifs associated terol and phospholipid concentrations cholesterol from HDL, while observa- with lipase activity (GXSXG and the increased by about 25 percent within 24 tions in individuals with mutations in catalytic triad S169, D193, H274), and hours of antibody administration. Inhi- hepatic lipase indicate that this enzyme with heparin binding were strongly bition of endothelial lipase activity hydrolyzes HDL triglycerides (10). In conserved (13, 14). Interestingly, in elicited more pronounced changes in contrast to both lipoprotein lipase and plasma lipid levels in hepatic Address correspondence to: Address hepatic lipase, endothelial lipase has lipase–deficient mice and in ApoAI correspondence to: Jonathan C. Cohen, little triglyceride hydrolase activity in transgenic mice. In the ApoAI trans- Center for Human Nutrition, University of vitro but instead cleaves fatty acids genic mice, antibody administration Texas Southwestern Medical Center at Dallas, from the sn-1 position of phos- was associated with a modest but statis- 5323 Harry Hines Boulevard, Dallas, Texas 75390-9052, USA. Phone: (214) 648-4774; phatidylcholine. In in vitro assays the tically significant reduction in HDL- Fax: (214) 648-4837; E-mail: enzyme is most active on lipids pre- phospholipid turnover. [email protected]. sented in HDL, although it will release These findings suggest that the meta- Conflict of interest: The author has declared fatty acids from all classes of lipopro- bolic pathways of the two major classes that no conflict of interest exists. teins (15). Consistent with this finding, of lipoproteins, apolipoprotein B con- Nonstandard abbreviations used: HDL cholesterol (HDL-C); coronary heart disease adenovirus-mediated overexpression of taining lipoproteins and HDL, may have (CHD); scavenger receptor BI (SR-BI); endothelial lipase in LDL receptor-defi- more in common than was previously endothelial lipase (LIPG). cient mice reduced plasma concentra- recognized, and that normal lipoprotein The Journal of Clinical Investigation | February 2003 | Volume 111 | Number 3 1 Figure 1 Sequence alignment of lipoprotein lipase (lpl), hepatic lipase (hl), and endothelial lipase (el) from human (h) and pufferfish Takifugu rubripes (f). Amino acids that are identical in all three genes in both species are shaded in grey. The serine, aspartic acid, and histidine resides of the catalytic triad, as well as the lipase motif (GXSXG) are boxed. The conserved cysteine residues are denoted with closed circles. The lid domain is indicated with a sin- gle line, and the conserved heparin-binding region (BBXB) is indicated with a double line. metabolism requires the action of three removed from the circulation by recep- The high degree of sequence conser- vascular endothelial lipases with distinct tor-mediated endocytosis. Consequent- vation among the three vascular substrate specificities. The catabolic ly, patients lacking lipoprotein lipase endothelial lipases suggests that they pathway for the apolipoprotein B con- accumulate very large, triglyceride-rich arose from a common ancestor and taining lipoproteins includes two lipoproteins (16), whereas genetic defects evolved distinct substrate specificities sequential steps; lipolysis and receptor- in hepatic lipase lead to the accumula- to accommodate the full spectrum of mediated endocytosis. Nascent triglyc- tion of partially-delipidated lipoproteins circulating lipoproteins. The duplica- eride-rich lipoproteins secreted from the of intermediate density (10). Now it tion events that (presumably) gave rise liver and intestine (chylomicrons and appears that high density lipoprotein to the three lipases must have occurred very low density lipoproteins) are delipi- metabolism may also include both a early in vertebrate evolution, since the dated first by lipoprotein lipase,
Recommended publications
  • Gentaur Products List
    Chapter 2 : Gentaur Products List • Rabbit Anti LAMR1 Polyclonal Antibody Cy5 Conjugated Conjugated • Rabbit Anti Podoplanin gp36 Polyclonal Antibody Cy5 • Rabbit Anti LAMR1 CT Polyclonal Antibody Cy5 • Rabbit Anti phospho NFKB p65 Ser536 Polyclonal Conjugated Conjugated Antibody Cy5 Conjugated • Rabbit Anti CHRNA7 Polyclonal Antibody Cy5 Conjugated • Rat Anti IAA Monoclonal Antibody Cy5 Conjugated • Rabbit Anti EV71 VP1 CT Polyclonal Antibody Cy5 • Rabbit Anti Connexin 40 Polyclonal Antibody Cy5 • Rabbit Anti IAA Indole 3 Acetic Acid Polyclonal Antibody Conjugated Conjugated Cy5 Conjugated • Rabbit Anti LHR CGR Polyclonal Antibody Cy5 Conjugated • Rabbit Anti Integrin beta 7 Polyclonal Antibody Cy5 • Rabbit Anti Natrexone Polyclonal Antibody Cy5 Conjugated • Rabbit Anti MMP 20 Polyclonal Antibody Cy5 Conjugated Conjugated • Rabbit Anti Melamine Polyclonal Antibody Cy5 Conjugated • Rabbit Anti BCHE NT Polyclonal Antibody Cy5 Conjugated • Rabbit Anti NAP1 NAP1L1 Polyclonal Antibody Cy5 • Rabbit Anti Acetyl p53 K382 Polyclonal Antibody Cy5 • Rabbit Anti BCHE CT Polyclonal Antibody Cy5 Conjugated Conjugated Conjugated • Rabbit Anti HPV16 E6 Polyclonal Antibody Cy5 Conjugated • Rabbit Anti CCP Polyclonal Antibody Cy5 Conjugated • Rabbit Anti JAK2 Polyclonal Antibody Cy5 Conjugated • Rabbit Anti HPV18 E6 Polyclonal Antibody Cy5 Conjugated • Rabbit Anti HDC Polyclonal Antibody Cy5 Conjugated • Rabbit Anti Microsporidia protien Polyclonal Antibody Cy5 • Rabbit Anti HPV16 E7 Polyclonal Antibody Cy5 Conjugated • Rabbit Anti Neurocan Polyclonal
    [Show full text]
  • The Metabolic Serine Hydrolases and Their Functions in Mammalian Physiology and Disease Jonathan Z
    REVIEW pubs.acs.org/CR The Metabolic Serine Hydrolases and Their Functions in Mammalian Physiology and Disease Jonathan Z. Long* and Benjamin F. Cravatt* The Skaggs Institute for Chemical Biology and Department of Chemical Physiology, The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, California 92037, United States CONTENTS 2.4. Other Phospholipases 6034 1. Introduction 6023 2.4.1. LIPG (Endothelial Lipase) 6034 2. Small-Molecule Hydrolases 6023 2.4.2. PLA1A (Phosphatidylserine-Specific 2.1. Intracellular Neutral Lipases 6023 PLA1) 6035 2.1.1. LIPE (Hormone-Sensitive Lipase) 6024 2.4.3. LIPH and LIPI (Phosphatidic Acid-Specific 2.1.2. PNPLA2 (Adipose Triglyceride Lipase) 6024 PLA1R and β) 6035 2.1.3. MGLL (Monoacylglycerol Lipase) 6025 2.4.4. PLB1 (Phospholipase B) 6035 2.1.4. DAGLA and DAGLB (Diacylglycerol Lipase 2.4.5. DDHD1 and DDHD2 (DDHD Domain R and β) 6026 Containing 1 and 2) 6035 2.1.5. CES3 (Carboxylesterase 3) 6026 2.4.6. ABHD4 (Alpha/Beta Hydrolase Domain 2.1.6. AADACL1 (Arylacetamide Deacetylase-like 1) 6026 Containing 4) 6036 2.1.7. ABHD6 (Alpha/Beta Hydrolase Domain 2.5. Small-Molecule Amidases 6036 Containing 6) 6027 2.5.1. FAAH and FAAH2 (Fatty Acid Amide 2.1.8. ABHD12 (Alpha/Beta Hydrolase Domain Hydrolase and FAAH2) 6036 Containing 12) 6027 2.5.2. AFMID (Arylformamidase) 6037 2.2. Extracellular Neutral Lipases 6027 2.6. Acyl-CoA Hydrolases 6037 2.2.1. PNLIP (Pancreatic Lipase) 6028 2.6.1. FASN (Fatty Acid Synthase) 6037 2.2.2. PNLIPRP1 and PNLIPR2 (Pancreatic 2.6.2.
    [Show full text]
  • 1 Endothelial Lipase Is Synthesized by Hepatic and Aorta Endothelial
    Endothelial Lipase Is Synthesized by Hepatic and Aorta Endothelial Cells and Its Expression Is Altered in apoE Deficient Mice Kenneth C-W. Yu†, Christopher David¶, Sujata Kadambi¶, Andreas Stahl†¶, Ken-Ichi Hirata†§, Tatsuro Ishida†§, Thomas Quertermous†, Allen D Cooper†¶ and Sungshin Y. Choi¶* Palo Alto Medical Foundation-Research Institute¶, Palo Alto, CA, School of Medicine, Stanford University†, Palo Alto, CA. *Corresponding author: Sungshin Y. Choi, Ph.D. Research Institute, Palo Alto Medical Foundation 795 El Camino Real – Ames Bldg. Palo Alto, CA 94301 650-853-2866 email address: [email protected] §: Current Address: Division of Cardiovascular and Respiratory Medicine, Kobe University Graduate School of Medicine, Kobe, Japan Short title: Tissue specific expression of endothelial lipase Abbreviations: EL = endothelial lipase, EC = endothelial cells, HL = hepatic lipase, LPL = lipoprotein lipase, EKO = apoE knockout, WT = wild-type, CA = cholic acid, HL = high fat, NC = normal chow, RT-PCR = real-time PCR, vWF = von Willbrand Factor, EC = endothelial cells. 1 ABSTRACT Both LPL and HL are synthesized in parenchymal cells, secreted and bind to endothelial cells. To learn where endothelial lipase (EL) is synthesized in the adult animals the localization of EL in mouse and rat liver was studied by immunohistochemical analysis. Further, to test if EL could play a role in atherogenesis, expression of EL in the aorta and liver of apoE knockout mice was determined. EL, in both mouse and rat liver was colocalized with the vascular endothelial cells and not hepatocytes. In contrast, hepatic lipase (HL) was present in both hepatocytes and endothelial cells. By in situ hybridization EL mRNA was present only in endothelial cells in liver sections.
    [Show full text]
  • Functionally Defective High-Density Lipoprotein and Paraoxonase: a Couple for Endothelial Dysfunction in Atherosclerosis
    Hindawi Publishing Corporation Cholesterol Volume 2013, Article ID 792090, 10 pages http://dx.doi.org/10.1155/2013/792090 Review Article Functionally Defective High-Density Lipoprotein and Paraoxonase: A Couple for Endothelial Dysfunction in Atherosclerosis Esin Eren,1 Necat Yilmaz,2,3 and Ozgur Aydin2 1 Laboratory of AtaturkHospital,07040Antalya,Turkey¨ 2 Central Laboratories of Antalya Education and Research Hospital of Ministry of Health, 07100 Antalya, Turkey 3 Antalya Egitim˘ ve Aras¸tırma Hastanesi Merkez Laboratuvarı Soguksu,˘ 07100 Antalya, Turkey Correspondence should be addressed to Necat Yilmaz; [email protected] Received 29 June 2013; Revised 8 August 2013; Accepted 12 August 2013 Academic Editor: Jeffrey Cohn Copyright © 2013 Esin Eren et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The endothelium is the primary target for biochemical or mechanical injuries caused by the putative risk factors of atherosclerosis. Endothelial dysfunction represents the ultimate link between atherosclerotic risk factors that promote atherosclerosis. HDL-C is thought to exert at least some parts of its antiatherogenic facilities via stimulating endothelial NO production, nearby inhibiting oxidative stress and inflammation. HDL-C is capable of opposing LDL’s inductive effects and avoiding the ox-LDL’s inhibition of eNOS. Paraoxonase 1 (PON1) is an HDL-associated enzyme esterase which appears to contribute to the antioxidant and antiatherosclerotic capabilities of HDL-C. “Healthy HDL,”namely the particle that contains the active Paraoxonase 1, has the power to suppress the formation of oxidized lipids.
    [Show full text]
  • 24651 Story.Indd
    Aetiology of Depression: Insights from epidemiological and genetic research Olivera Story-Jovanova Acknowledgments: Financial support for the publication of this thesis by the Department of Epidemiology of the Erasmus MC, is gratefully acknowledged. ISBN: 978-94-6233-909-5 Cover: Concept by Olivera Story-Jovanova, design by Chris van Wolferen-Ketel, photography by Michal Macku. Layout: Gildeprint, Enschede. Printing: Gildeprint, Enschede. © Olivera Story-Jovanova, 2018 For all articles published, the copyright has been transferred to the respective publisher. No part of this thesis may be stored in a retrieval system, or transmitted in any form or by any means, without written permission from the author or, when appropriate, from the publisher. Aetiology of Depression: Insights from epidemiological and genetic research Etiologie van depressie: Inzichten vanuit de epidemiologisch en de genetisch onderzoek Proefschrift ter verkrijging van de graad van doctor aan de Erasmus Universiteit Rotterdam op gezag van de rector magnificus Prof. dr. H.A.P. Pols en volgens besluit van het College voor Promoties. De openbare verdediging zal plaatsvinden op 4 April 2018 om 15:30 uur door Olivera Story-Jovanova geboren te Skopje, Macedonia PROMOTIECOMMISSIE Promotor Prof. dr. H. Tiemeier Overige leden Prof. D. Boomsma Prof. K. Berger Prof. C. van Duijn Copromotor Dr. N. Amin Paranimfen Ayesha Sajjad Dina Atlas For my husband, children, sister, parents, grandparents, my parents in law and all you who believed in me. You are a gift of unconditional love, acceptance, joy and wisdom. I am thankful for that! ACKNOWLEDGEMENTS The research described in this thesis was performed within the frame work of the Rotterdam Study.
    [Show full text]
  • Clinical Efficacy of Serum Lipase Subtype Analy- Sis for the Differential Diagnosis of Pancreatic and Non-Pancreatic Lipase Elevation
    ORIGINAL ARTICLE Korean J Intern Med 2016;31:660-668 http://dx.doi.org/10.3904/kjim.2015.007 Clinical efficacy of serum lipase subtype analy- sis for the differential diagnosis of pancreatic and non-pancreatic lipase elevation Chang Seok Bang*, Jin Bong Kim*, Sang Hyun Park, Gwang Ho Baik, Ki Tae Su, Jai Hoon Yoon, Yeon Soo Kim, and Dong Joon Kim Department of Internal Medicine, Background/Aims: Non-pancreatic elevations of serum lipase have been reported, Hallym University College of and differential diagnosis is necessary for clinical practice. This study aimed to Medicine, Chuncheon, Korea evaluate the clinical efficacy of serum lipase subtype analysis for the differential diagnosis of pancreatic and non-pancreatic lipase elevation. Methods: Patients who were referred for the serum lipase elevation were prospec- tively enrolled. Clinical findings and serum lipase subtypes were analyzed and compared by dividing the patients into pancreatitis and non-pancreatitis groups. Results: A total of 34 patients (12 pancreatitis vs. 22 non-pancreatitis cases) were enrolled. In univariate analysis, the fraction of pancreatic lipase (FPL) in the total amount of serum lipase subtypes was statistically higher in patients with pancre- atitis ([median, 0.004; interquartile range [IQR], 0.003 to 0.011] vs. [median, 0.002; IQR, 0.001 to 0.004], p = 0.04). Based on receiver operating characteristic curve Received : January 11, 2015 Revised : May 23, 2015 analysis for the prediction of acute pancreatitis, FPL was the most valuable pre- Accepted : June 9, 2015 dictor (area under the receiver-operating characteristic curve [AUROC], 0.72; 95% confidence interval [CI], 0.54 to 0.86; sensitivity, 83.3%; specificity, 63.6%; positive Correspondence to Jin Bong Kim, M.D.
    [Show full text]
  • Inhibition of Endothelial Notch Signaling Impairs Fatty Acid Transport and Leads to Metabolic and Vascular Remodeling of the Adult Heart Markus Jabs, Adam J
    10.1161/CIRCULATIONAHA.117.029733 Inhibition of Endothelial Notch Signaling Impairs Fatty Acid Transport and Leads to Metabolic and Vascular Remodeling of the Adult Heart Running Title: Jabs et al.; Heart failure After Endothelial Notch Inhibition Markus Jabs, PhD, et al. The full author list is available on page 19. Downloaded from Address for Correspondence: AAndreasndreas FischerFischer,, MMDD http://circ.ahajournals.org/ GGermanerman CCancerancer Research CCenterenter VVascularascular Signaling and Cancer (A270) Imm NNeuenheimereuenheimer FFeldeld 282800 6692109210 Heidelberg,Heidelberg, GermanyGermany TeTel:l: +4+499 62622121 42 414415050 FFax:axx: ++4+499 626221211 4422 414415959 by guest on March 20, 2018 Email:Emmail: [email protected]@@ddkfzz.de 1 10.1161/CIRCULATIONAHA.117.029733 Abstract Background—Nutrients are transported through endothelial cells before being metabolized in muscle cells. However, little is known about the regulation of endothelial transport processes. Notch signaling is a critical regulator of metabolism and angiogenesis during development. Here, we studied how genetic and pharmacological manipulation of endothelial Notch signaling in adult mice affects endothelial fatty acid transport, cardiac angiogenesis, and heart function. Methods—Endothelial-specific Notch inhibition was achieved by conditional genetic inactivation of Rbp-jκ in adult mice to analyze fatty acid metabolism and heart function. Wild- type mice were treated with neutralizing antibodies against the Notch ligand Dll4. Fatty acid transport was studied in cultured endothelial cells and transgenic mice. Results—Treatment of wild-type mice with Dll4 neutralizing antibodies for eight weeks impaired fractional shortening and ejection fraction in the majority of mice. Inhibition of Notch signaling specifically in the endothelium of adult mice by genetic ablation of Rbp-jκ caused heart Downloaded from hypertrophy and failure.
    [Show full text]
  • Alterations in Plasma and Tissue Lipids Associated with Obesity and Metabolic Syndrome
    Clinical Science (2008) 114, 183–193 (Printed in Great Britain) doi:10.1042/CS20070115 183 REVIEW Alterations in plasma and tissue lipids associated with obesity and metabolic syndrome Concepcion´ M. AGUILERA∗, Mercedes GIL-CAMPOS†, Ramon´ CANETE˜ † and Angel´ GIL∗ ∗Department of Biochemistry and Molecular Biology II, Institute of Nutrition and Food Technology, School of Pharmacy, University of Granada, Campus de Cartuja 18071 Granada, Spain, and †Unit of Pediatric Endocrinology, Reina Sofia University Hospital, Avda Men´endez Pidal s/n, Cordoba,´ Spain ABSTRACT The MS (metabolic syndrome) is a cluster of clinical and biochemical abnormalities charac- terized by central obesity, dyslipidaemia [hypertriglyceridaemia and decreased HDL-C (high- density lipoprotein cholesterol)], glucose intolerance and hypertension. Insulin resistance, hyperleptinaemia and low plasma levels of adiponectin are also widely related to features of the MS. This review focuses on lipid metabolism alterations associated with the MS, paying special attention to changes in plasma lipids and cellular fatty acid oxidation. Lipid metabolism alterations in liver and peripheral tissues are addressed, with particular reference to adipose and muscle tissues, and the mechanisms by which some adipokines, namely leptin and adiponectin, mediate the regulation of fatty acid oxidation in those tissues. Activation of the AMPK (AMP- dependent kinase) pathway, together with a subsequent increase in fatty acid oxidation, appear to constitute the main mechanism of action of these hormones in the regulation of lipid metabolism. Decreased activation of AMPK appears to have a role in the development of features of the MS. In addition, alteration of AMPK signalling in the hypothalamus, which may function as a sensor of nutrient availability, integrating multiple nutritional and hormonal signals, may have a key role in the appearance of the MS.
    [Show full text]
  • Glycerophospholipid and Sphingolipid Species and Mortality: the Ludwigshafen Risk and Cardiovascular Health (LURIC) Study
    Glycerophospholipid and Sphingolipid Species and Mortality: The Ludwigshafen Risk and Cardiovascular Health (LURIC) Study Alexander Sigruener1*, Marcus E. Kleber2, Susanne Heimerl1, Gerhard Liebisch1, Gerd Schmitz1, Winfried Maerz2,3,4 1 Institute for Laboratory Medicine and Transfusion Medicine, Regensburg University Medical Center, Regensburg, Germany, 2 Medical Clinic V, Mannheim Medical Faculty, University of Heidelberg, Mannheim, Germany, 3 Clinical Institute of Medical and Chemical Laboratory Diagnostics, Medical University of Graz, Graz, Austria, 4 Synlab Academy, Synlab Services GmbH, Mannheim, Germany Abstract Vascular and metabolic diseases cause half of total mortality in Europe. New prognostic markers would provide a valuable tool to improve outcome. First evidence supports the usefulness of plasma lipid species as easily accessible markers for certain diseases. Here we analyzed association of plasma lipid species with mortality in the Ludwigshafen Risk and Cardiovascular Health (LURIC) study. Plasma lipid species were quantified by electrospray ionization tandem mass spectrometry and Cox proportional hazards regression was applied to assess their association with total and cardiovascular mortality. Overall no differences were detected between total and cardiovascular mortality. Highly polyunsaturated phosphatidylcholine species together with lysophosphatidylcholine species and long chain saturated sphingomyelin and ceramide species seem to be associated with a protective effect. The predominantly circulating phosphatidylcholine-based
    [Show full text]
  • Phospholipases of Mineralization Competent Cells and Matrix Vesicles: Roles in Physiological and Pathological Mineralizations
    Int. J. Mol. Sci. 2013, 14, 5036-5129; doi:10.3390/ijms14035036 OPEN ACCESS International Journal of Molecular Sciences ISSN 1422-0067 www.mdpi.com/journal/ijms Review Phospholipases of Mineralization Competent Cells and Matrix Vesicles: Roles in Physiological and Pathological Mineralizations Saida Mebarek 1,2,3,4,5,*, Abdelkarim Abousalham 1,2,3,4,5, David Magne 1,2,3,4,5, Le Duy Do 1,2,3,4,5,6, Joanna Bandorowicz-Pikula 6, Slawomir Pikula 6 and René Buchet 1,2,3,4,5 1 Université de Lyon, Lyon, F-69361, France; E-Mails: [email protected] (A.A.); [email protected] (D.M.); [email protected] (L.D.D.); [email protected] (R.B.) 2 Université Lyon 1, Villeurbanne, F-69622, France 3 INSA-Lyon, Villeurbanne, F-69622, France 4 CPE Lyon, Villeurbanne, F-69616, France 5 ICBMS CNRS UMR 5246, Villeurbanne, F-69622, France 6 Department of Biochemistry, Nencki Institute of Experimental Biology, Polish Academy of Sciences, Pasteura 3, 02-093 Warsaw, Poland; E-Mails: [email protected] (J.B.-P.); [email protected] (S.P.) * Author to whom correspondence should be addressed; E-Mail: [email protected]; Tel.: +33-4-264-344-00; Fax: +33-4-724-315-43. Received: 4 December 2012; in revised form: 24 January 2013 / Accepted: 25 January 2013 / Published: 1 March 2013 Abstract: The present review aims to systematically and critically analyze the current knowledge on phospholipases and their role in physiological and pathological mineralization undertaken by mineralization competent cells.
    [Show full text]
  • The Substrate Specificities of Hepatic Lipase and Endothelial Lipase for High Density Lipoprotein Phospholipids
    ,\ô, THE SUBSTRATE SPECIFICITIBS OF HEPATIC LIPASE AND ENDOTHELIAL LIPASE FOR HIGH DENSITY LIPOPROTEIN PHOSPHOLIPIDS: A COMPARATIVE STUDY. My Ngan Duong B.Sc. B.Sc (Hons). A thesis submitted in fulfilment of the requirements for the Degree of Doctor of Philosophy Department of Medicine Adelaide University Adelaide, Australia. March 2003 11 TABLE OF CONTENTS SUMMARY..... 111 DECLARATION.. .v ACKNOWLEDGEMENTS .vi PUBLICATIONS AND ABSTRACTS vii ABREVIATIONS .ix CHAPTER 1 INTRODUCTION...... 1 CHAPTER 2 MATERIALS AND METHODS........ 52 CHAPTER 3 HYDROLYSIS OF PHOSPHOLIPIDS IN SPMRICAL (POPC)rHDL, (PLPC)rHDL, (PAPC)rHDL AND (PDPC)rHDL BY HL AND EL.. 68 CHAPTER 4 HYDROLYSIS OF TRIGLYCERIDES IN SPMRICAL (POPC)rHDL, (PLPC)rHDL, (PAPC)rHDL AND (PDPC)rHDL BY HL AND EL... 80 CITPATER 5 TIIE DEVELOPMENT OF A NOVEL SPECTROSCOPIC APPROACH FOR QUANTITATE HL-MEDIATED PHO SPHOLIPID HYDROLYSN 94 CHAPTER 6 CONCLUDING COMMENTS 108 BIBLIOGRAPHY... .111 ll1 S[]MMARY Hepatic lipase (HL) and endothelial lipase (EL) are both members of the triglyceride lipase gene family that preferentially hydrolyses high density lipoproteins (HDL) and are involved in the in vivo metabolism and regulation of HDL. Both HL and EL hydrolyses HDL phospholipids. The main HDL phospholipid species are phosphatidylcholines, with the four most abundant being, 1-palmitoyl-2-oleoyl phosphatidylcholine (POPC), 1-palmitoyl-2-linoleoyl phosphatidylcholine PLPC, 1- palmitoyl-2-arachidonoyl phosphatidylcholine (PAPC) and 1-palmitoyl-2- docosahexanoyl phosphatidylcholine (PDPC). The aim of this thesis was to determine if HL and EL have different substrate specificities for HDL phospholipids' In order to carry out these studies, it was important to use HDL that varied systematically in their phospholipid composition, but which were comparable in all other respects.
    [Show full text]
  • Kent Academic Repository Full Text Document (Pdf)
    Kent Academic Repository Full text document (pdf) Citation for published version Alexander, Stephen PH and Fabbro, Doriano and Kelly, Eamonn and Mathie, Alistair and Peters, John A and Veale, Emma L. and Armstrong, Jane F and Faccenda, Elena and Harding, Simon D and Pawson, Adam J and Sharman, Joanna L and Southan, Christopher and Davies, Jamie A and Beuve, Annie and Boison, Detlev and Brouckaert, Peter and Burnett, John C and Burns, Kathryn DOI https://doi.org/10.1111/bph.14752 Link to record in KAR https://kar.kent.ac.uk/78599/ Document Version Publisher pdf Copyright & reuse Content in the Kent Academic Repository is made available for research purposes. Unless otherwise stated all content is protected by copyright and in the absence of an open licence (eg Creative Commons), permissions for further reuse of content should be sought from the publisher, author or other copyright holder. Versions of research The version in the Kent Academic Repository may differ from the final published version. Users are advised to check http://kar.kent.ac.uk for the status of the paper. Users should always cite the published version of record. Enquiries For any further enquiries regarding the licence status of this document, please contact: [email protected] If you believe this document infringes copyright then please contact the KAR admin team with the take-down information provided at http://kar.kent.ac.uk/contact.html S.P.H. Alexander et al. The Concise Guide to PHARMACOLOGY 2019/20: Enzymes. British Journal of Pharmacology (2019) 176, S297–S396
    [Show full text]